あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/05/12 | 日証協 | 156,623株 | -19.81% | 39,548株 | +190.77% | 383,310株 | -11.15% | 27,176株 | +239.7% |
2017/05/02 | 日証協 | 195,324株 | +0.37% | 13,601株 | -82.77% | 431,417株 | -1.78% | 8,000株 | -84.37% |
2017/04/28 | 日証協 | 194,598株 | +17.64% | 78,928株 | +155.42% | 439,217株 | +6.73% | 51,182株 | +188.25% |
2017/04/21 | 日証協 | 165,424株 | -28.83% | 30,901株 | -27.48% | 411,509株 | -19.73% | 17,756株 | -45.37% |
2017/04/14 | 日証協 | 232,435株 | -33.4% | 42,612株 | -89.01% | 512,664株 | -18.06% | 32,501株 | -87.4% |
2017/04/07 | 日証協 | 349,011株 | -0.96% | 387,604株 | +41.82% | 625,663株 | +0.69% | 258,018株 | +11.88% |
2017/03/31 | 日証協 | 352,411株 | +85.18% | 273,316株 | +913.9% | 621,385株 | +33.31% | 230,622株 | +755.36% |
2017/03/24 | 日証協 | 190,310株 | -1.64% | 26,957株 | +147.29% | 466,119株 | +1.77% | 26,962株 | -73.92% |
2017/03/17 | 日証協 | 193,480株 | -12.73% | 10,901株 | -66.3% | 458,017株 | +8.36% | 103,392株 | +798.83% |
2017/03/10 | 日証協 | 221,699株 | +3.13% | 32,348株 | +232.52% | 422,672株 | -3.22% | 11,503株 | -77.73% |
2017/03/03 | 日証協 | 214,979株 | +2.92% | 9,728株 | -36% | 436,718株 | -4.43% | 51,644株 | +140% |
2017/02/24 | 日証協 | 208,879株 | -0.64% | 15,200株 | +294.19% | 456,951株 | -1.1% | 21,518株 | +17.82% |
2017/02/17 | 日証協 | 210,235株 | -6.58% | 3,856株 | -87.85% | 462,023株 | -0.94% | 18,264株 | -64.23% |
2017/02/10 | 日証協 | 225,053株 | -5.87% | 31,748株 | +12.71% | 466,423株 | +1.02% | 51,064株 | +23.61% |
2017/02/03 | 日証協 | 239,079株 | +5.58% | 28,168株 | +109.33% | 461,721株 | +2.66% | 41,311株 | +67.63% |
2017/01/27 | 日証協 | 226,435株 | -1.86% | 13,456株 | -80.76% | 449,754株 | +1.15% | 24,644株 | +164.14% |
2017/01/20 | 日証協 | 230,735株 | +9.46% | 69,935株 | +883.61% | 444,649株 | -2.86% | 9,330株 | -27.96% |
2017/01/13 | 日証協 | 210,803株 | -6.68% | 7,110株 | -75.54% | 457,762株 | -1.93% | 12,952株 | -33.6% |
2017/01/06 | 日証協 | 225,903株 | -10.3% | 29,069株 | +27.18% | 466,756株 | -4.95% | 19,506株 | -30.83% |
※株式分割は考慮していませんのでご注意ください。
Page Top